Network Financial Overview
Annual Revenue
₹1,550 Cr
EBITDA
₹490 Cr
31.6% margin
Monthly Rate
₹129 Cr
Total Hospitals
30
Total Beds
3,200
Bed Occupancy
71%
Monthly Footfall
1,85,000
ICU Occupancy
82%
NICU Occupancy
88%
OT Utilization
76%
Revenue Leakage
₹4.8 Cr
Per month
Patient Experience
84/100
NABH Compliance
88/100
JCI Readiness
81/100
Energy Cost
₹6.2 Cr
Per month
EBITDA Protection
₹28–36 Cr
Annually
Hospital Tier Performance
Tier 1 — Metro (5 Hospitals)
Hyderabad · Bengaluru · Chennai · Delhi · Mumbai
Occupancy
79%
Rev Share
58%
EBITDA%
34.2%
ICU Occ.
87%
Tier 2 — Regional (13 Hospitals)
Vizag · Vijayawada · Coimbatore · Kochi · Pune + 8 more
Occupancy
68%
Rev Share
32%
EBITDA%
29.8%
ICU Occ.
76%
Tier 3 — Hub & Spoke (12 Hospitals)
Regional Pediatric Centers · Referral Network
Occupancy
61%
Rev Share
10%
EBITDA%
24.1%
Referral↑
+11%
Patient Flow Forecast
Current Footfall
1,85,000
May-2026 Forecast
1,87,000
Peak Month
Oct-2026
2,04,000 est.
NICU/Month
1,840
Emergency/Month
22,400
Referral Growth
+11%
Monthly Patient Footfall — Actual & Forecast
Actual (orange) + Forecast (blue dashed)
| Month | Total | Tier 1 | Tier 2 | ICU | NICU | Emergency |
|---|---|---|---|---|---|---|
| May-2026 | 1,87,000 | 92,000 | 61,000 | 1,480 | 1,860 | 22,600 |
| Jul-2026 | 1,78,000 | 87,000 | 58,100 | 1,560 | 1,900 | 24,200 |
| Aug-2026 | 1,91,000 | 94,000 | 62,000 | 1,640 | 2,040 | 26,400 |
| Sep-2026 | 1,96,000 | 96,000 | 63,800 | 1,720 | 2,120 | 28,800 |
| Oct-2026 | 2,04,000 | 1,00,000 | 66,400 | 1,840 | 2,280 | 31,200 |
Predictive Model Performance
LSTM Neural Network
Forecast Accuracy94.2%
MAPE5.8%
Confidence Interval±4.6%
XGBoost Ensemble
Forecast Accuracy93.1%
MAPE6.3%
Confidence Interval±5.1%
Seasonal Intelligence
Respiratory surge expected Aug–Oct 2026 in Tier 1 metros. Tier 2 showing 18% increase in neonatal admissions. ICU demand forecast exceeds capacity threshold at Hyderabad and Bengaluru by Sep-2026.
Revenue & Revenue Leakage
Total Monthly Leakage
₹4.8 Cr
Insurance Delay
₹1.6 Cr
Unbilled Procedures
₹0.9 Cr
OT Idle Time
₹1.1 Cr
Pharmacy Leakage
₹0.7 Cr
Discharge Delay
₹0.5 Cr
Payer Mix — Cash
42%
Insurance AR Days
48
Revenue Leakage by Category (₹ Cr/month)
Total ₹4.8 Cr recoverable
| Insurer | Pending | Avg Delay | Approval% | Held | Risk |
|---|---|---|---|---|---|
| Star Health | 186 | 18.4 hrs | 91% | ₹38.4L | Med |
| PMJAY/Ayushman | 248 | 31.2 hrs | 84% | ₹62.8L | High |
| New India | 124 | 14.6 hrs | 88% | ₹28.4L | Med |
| HDFC Ergo | 96 | 9.8 hrs | 94% | ₹18.2L | Low |
Revenue Intelligence
Insurance authorization delays extending average discharge cycle by 7.4 hours. PMJAY cases show highest auth delay (31.2 hrs avg). Dedicated authorization desk per Tier 1 hospital can recover ₹1.2–1.4 Cr/month.
Consumables Intelligence
Active SKUs
12,400
Expiry Risk
₹1.8 Cr
Fast Moving SKUs
420
Critical Shortage
18 SKUs
Inventory Days
29
Procurement Saving
₹2.4 Cr
Slow-Moving Stock
₹3.6 Cr
Supplier Count
284
Top Consumable Categories — Monthly Cost (₹ Lakhs)
Network-wide consumption
| SKU Category | Monthly Usage | Days Cover | Shortage | Action |
|---|---|---|---|---|
| IV Cannula 24G | 84,000 | 4 days | Critical | Emergency PO today |
| Neonatal ET Tubes | 2,840 | 4 days | Critical | Emergency PO today |
| Surgical Gloves | 1,42,000 | 6 days | High | Order 24 hrs |
| Infusion Pumps | 18,400 | 10 days | Med | Reorder this week |
| Suction Catheters | 22,400 | 25 days | Low | Normal replenishment |
Medicine Demand Prediction
Total Medicine Cost
₹18.4 Cr
Per month
High Volatility Drugs
4
Stockout Risk
3 Drugs
Procurement Saving
₹2.8 Cr
Import Dependent
6 Drugs
Generic Substitution
₹1.2 Cr
Monthly opp.
Top Medicine Monthly Cost — Current vs Forecast (₹ Lakhs)
Blue=Current · Orange=Forecast
| Medicine | Current Units | Forecast | Volatility | Risk | EBITDA Exp. |
|---|---|---|---|---|---|
| Ceftriaxone | 1,82,000 | 2,01,000 | High | Med | ₹0.8 Cr |
| Meropenem | 48,400 | 58,200 | High | High | ₹1.4 Cr |
| Human Albumin | 8,200 | 9,840 | High | High | ₹1.8 Cr |
| Dopamine | 12,400 | 14,800 | Med | High | ₹0.6 Cr |
| Salbutamol | 1,24,000 | 1,68,000 | High | Med | ₹0.4 Cr |
| Vancomycin | 24,600 | 28,400 | Med | Med | ₹0.9 Cr |
Critical Drug Alert
Meropenem and Human Albumin price volatility increasing due to imported API dependency. Salbutamol demand forecast to spike 35% in Aug–Sep respiratory season. Combined EBITDA exposure: ₹3.6 Cr. Secure multi-supplier contracts immediately.
Resource & Workforce Intelligence
Nursing OT Cost
₹1.4 Cr
Per month
Doctor Utilization
78%
Nurse Utilization
84%
Attrition Risk
12%
Agency Nursing
₹0.9 Cr
Fatigue Alerts
84
ICU Staffing Risk
Medium
Vacancy Rate
8.4%
OT Hours by Department (Monthly Network)
Overtime hours — NICU highest risk
| Hospital | Tier | Nurse OT | Fatigue | Vacancy | Agency Dep. | Risk |
|---|---|---|---|---|---|---|
| Hyderabad | T1 | 214 hrs | 18 | 9.2% | High | High |
| Bengaluru | T1 | 188 hrs | 14 | 8.6% | Med | Med |
| Chennai | T1 | 172 hrs | 12 | 6.8% | Med | Med |
| Vizag | T2 | 124 hrs | 8 | 5.4% | Low | Low |
Workforce Risk
Tier 1 NICU staffing showing elevated overtime risk. Night-shift nursing exceeds threshold in 4 hospitals. Agency cost of ₹0.9 Cr reducible by 40% through predictive roster optimisation. 12% attrition risk requires structured retention with 12% pay revision.
OT / ICU Utilization Intelligence
OT Utilization
76%
ICU Occupancy
82%
NICU Occupancy
88%
Avg Surgery Delay
41 mins
Emergency OT
18%
ICU Turnaround Delay
6.2 hrs
OT Idle Slots/Week
48
OT Revenue Lost
₹1.1 Cr
Monthly
ICU & NICU Occupancy Trend (6 Months)
Both rising — NICU approaching capacity
Critical ICU Alert
NICU at 88% — Hyderabad and Bengaluru projected to hit 96% by Jun-2026. ICU turnaround delay of 6.2 hours creating bed crunch. Combined revenue impact: ₹2.4 Cr/month in lost capacity.
Marketing & Growth Intelligence
Monthly Leads
14,800
Conversion Rate
21%
Referral Share
42%
Digital Acq. Cost
₹1,480
Per patient
Occupancy Growth
+6%
Google Rating
4.4 / 5
Brand NPS
68
Marketing Spend
₹4.2 Cr
Per month
Lead Source Distribution (%)
Doctor referral dominates at 42%
Growth Intelligence
Doctor referral network (42%) is highest-quality lead source at ₹480/patient acquisition cost. Digital channels at ₹1,480/patient require optimisation. Specialty campaigns for NICU and paediatric cardiac can drive 8–10% occupancy uplift in Tier 2 hospitals.
Patient CX Intelligence
NPS Score
68
Satisfaction
84%
Avg OPD Wait
32 mins
Complaint SLA
89%
Discharge Score
81%
Repeat Visit Rate
64%
Escalated Complaints
48
App Rating
4.3 / 5
Complaint Categories (%)
48 escalated this month — wait time dominates
CX Intelligence
Discharge is weakest CX touchpoint (81%) — driven by billing waits and insurance delays adding 7.4 hours. OPD wait of 32 minutes exceeds 20-minute target. Predictive appointment scheduling can reduce wait to 18 minutes and improve NPS by 8–12 points.
NABH / JCI Quality Intelligence
NABH Compliance
88 / 100
JCI Readiness
81 / 100
Open CAPA Actions
126
Infection Control
92%
Medication Errors
11
Critical Audit Risk
4 Areas
Documentation Gaps
284
HAI Rate
0.8%
NABH Compliance by Chapter (Score/100)
Clinical Outcomes at 76 = non-compliant risk
| Quality Area | Score | CAPAs | Status | JCI Impact | Due |
|---|---|---|---|---|---|
| Medication Mgmt | 82/100 | 28 | At Risk | High | 25 May |
| Infection Control | 92/100 | 8 | Compliant | Low | 15 Jun |
| Clinical Outcomes | 76/100 | 42 | Non-Compliant | Critical | 20 May |
| Facility Mgmt | 84/100 | 18 | Review | Med | 30 May |
| Staff Qualif. | 91/100 | 6 | Compliant | Low | 30 Jun |
Energy & Utility Intelligence
Monthly Energy Cost
₹6.2 Cr
Cost / Bed / Month
₹19,400
HVAC Share
41%
Generator Diesel
₹1.1 Cr
Water / Bed / Day
1,240 L
Leakage Opp.
₹1.8 Cr
Annually
Solar Coverage
12%
Expand to 28%
Peak Penalty
₹0.48 Cr
Energy Cost by Source (%) & Cost per Bed by Tier (₹)
HVAC dominates at 41% · Tier 1 highest per-bed cost
Energy Optimisation
₹1.8 Cr annually recoverable: HVAC scheduling in low-occupancy wards ₹0.6 Cr · Solar expansion 12%→28% ₹0.5 Cr · Peak demand load shifting ₹0.4 Cr · DG reduction ₹0.3 Cr.
Predictive EHS Management
Daily Movements
12,400
High-Risk Zones
7
Near Misses
18
Bio-Med Waste
91%
Elevator Congestion
Medium
Fire Readiness
89%
Ambulance Turnaround
14.2 mins
Visitor Congestion
Medium
Risk Zone Scores
Emergency→PICU transfer highest risk at 91
EHS Alert
ICU transfer congestion between Emergency and PICU during 18:00–21:00 increasing patient movement delay risk by 24%. Pharmacy-to-ward cart routes intersecting with ICU corridors in 3 Tier 1 hospitals. Bio-medical waste compliance at 91% — improve in 4 Tier 2 locations before next inspection.
| Zone | Peak Hours | Near Misses | Risk | Action |
|---|---|---|---|---|
| Emerg→PICU | 18:00–21:00 | 6 | 91 | Dedicated transfer lane |
| ICU Med Corr. | 08:00–10:00 | 4 | 78 | Reroute carts |
| NICU Entry | All hours | 3 | 74 | Visitor protocol |
| Ambulance Bay | 20:00–23:00 | 3 | 68 | Traffic coordinator |
New Projects & Expansion Intelligence
Capex Pipeline
₹420 Cr
New Beds Planned
620
Projects Executing
4
Avg Payback
4.2 yrs
Ramp-up Time
18–24 mos
Proj. Revenue
₹180 Cr
Full occupancy
Project IRR by Location (%)
Hyderabad highest at 26% — priority project
| Project | Beds | Capex | Status | Completion | IRR |
|---|---|---|---|---|---|
| Hyderabad Tower | 180 | ₹128 Cr | Construction | Dec-2026 | 26% |
| Indore Greenfield | 120 | ₹86 Cr | Foundation | Jun-2027 | 21% |
| Pune Expansion | 80 | ₹54 Cr | Interior | Sep-2026 | 23% |
| Bhubaneswar | 100 | ₹72 Cr | Planning | Mar-2028 | 18% |
| Vizag Hub | 140 | ₹80 Cr | Civil Works | Feb-2027 | 24% |
Expansion Intelligence
Hyderabad tower has highest IRR (26%) due to brand strength and NICU overflow demand. Pune delivers fastest ramp-up at 68% occupancy in Year 1. Prioritise these two for capex acceleration.
CFO Financial Intelligence
EBITDA Margin
31.6%
Annual EBITDA
₹490 Cr
AR Days
48
Target: 32
Working Capital
Medium Stress
Procurement Saving
₹8.4 Cr
Cost per Patient
₹4,840
ROCE
18.4%
Debt / EBITDA
1.8x
Monthly EBITDA Trend (₹ Cr) — Last 12 Months
Consistent 38–44 Cr range
AR Aging Analysis
| Aging Bucket | Amount | % of AR | Risk | Action |
|---|---|---|---|---|
| 0–30 Days | ₹48.2 Cr | 38% | Low | Normal collection |
| 31–60 Days | ₹34.6 Cr | 27% | Med | Follow-up this week |
| 61–90 Days | ₹22.8 Cr | 18% | Med | Escalate to TPA |
| 91–180 Days | ₹14.4 Cr | 11% | High | Legal notice |
| 180+ Days | ₹7.6 Cr | 6% | Bad Debt | Write-off analysis |
CFO Intelligence
AR days at 48 vs target of 32 represents ₹22–28 Cr trapped working capital. Reducing to 36 days frees ₹16 Cr cash. Centralised procurement across 30 hospitals delivers ₹8.4 Cr annual savings.
CEO Strategic Risk Dashboard
Critical Risks
3
High Risks
5
Total Exposure
₹84 Cr
Actionable This Month
6
🔴 ICU / NICU Capacity Breach88%
Impact
Patient overflowExposure
₹18 CrTimeline
Jun–Sep 2026Probability
88%CEO Decision
Accelerate Hyderabad tower by 8 weeks. Activate transfer protocol with partner hospitals. Add 24 modular NICU beds at Bengaluru and Chennai immediately.
🔴 Clinical Nursing Shortage74%
Impact
Care quality + OT delaysExposure
₹12 CrCEO Decision
Approve nursing retention programme with 12% pay revision. Partner with 3 nursing colleges for dedicated pipeline. Target agency dependency reduction by ₹0.6 Cr/month.
🟡 Medicine Inflation & Import Risk71%
Impact
Cost per patient risesExposure
₹8.4 CrCEO Decision
Lock 90-day supply contracts for Meropenem, Human Albumin, Vancomycin. Approve 8% formulary review. Centralise procurement across 30 hospitals for ₹8.4 Cr negotiation leverage.
🟡 Insurance AR & Working Capital68%
Impact
₹22 Cr trappedExposure
₹22 Cr ARCEO Decision
Deploy dedicated authorization teams at all 5 Tier 1 hospitals. Implement pre-authorization for elective procedures. Target AR from 48 to 36 days within 90 days — frees ₹16 Cr cash.
🔵 JCI Compliance Gap62%
Exposure
₹6 CrScore
81/100CEO Decision
Close 42 Clinical Outcomes CAPAs before Aug-2026 JCI review window. Prioritise Medication Management chapter — 28 open actions.
PerformIQ Strategic Intelligence
PerformIQ helps R Children's Hospital predict patient demand, optimise resources, reduce revenue leakage, improve clinical operations, control consumables, strengthen quality compliance, and protect EBITDA before operational inefficiencies impact care delivery. Total addressable EBITDA protection: ₹28–36 Cr annually.